-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LtjpVRP5Z+5mGeLrG18nIMSQq8Jv+eUxnfbnO87kzQOATIS+WSTJ6BjTKEoe0Z3P Q6RzN4QNNZrViv8GElNkjQ== 0001193805-10-002412.txt : 20100916 0001193805-10-002412.hdr.sgml : 20100916 20100916161608 ACCESSION NUMBER: 0001193805-10-002412 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100916 DATE AS OF CHANGE: 20100916 GROUP MEMBERS: DEERFIELD CAPITAL, L.P. GROUP MEMBERS: DEERFIELD MANAGEMENT COMPANY, L.P. GROUP MEMBERS: DEERFIELD PRIVATE DESIGN FUND, L.P. GROUP MEMBERS: DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P. GROUP MEMBERS: DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED GROUP MEMBERS: DEERFIELD SPECIAL SITUATIONS FUND, L.P. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Flynn James E CENTRAL INDEX KEY: 0001352546 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hana Biosciences Inc CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841588441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79910 FILM NUMBER: 101076159 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6505886404 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 SC 13D/A 1 e607515_13da-hana.htm Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
 
[Rule 13d-101]

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 24.13d-1(a) AND AMENDMENT THERETO FILED PURSUANT TO § 240.13D-2(a)

(Amendment No. 2)*
 
HANA BIOSCIENCES, INC.
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
40963P204
(CUSIP Number)
 
 
James E. Flynn
Deerfield Capital, L.P.
780 Third Avenue, 37th Floor
New York, New York  10017
(212) 551-1600
 
With a copy to:
 
Mark I. Fisher, Esq.
Elliot Press, Esq.
Katten Muchin Rosenman LLP
575 Madison Avenue
New York, New York  10022
(212) 940-8800
 
 
 
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
September 10, 2010
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
 
Note:   Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.
 
(Continued on following pages)
(Page 1 of 13 Pages)
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 2 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Capital, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
8,839,989 Shares (1)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
8,839,989 Shares (1)(2)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,839,989 Shares (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
33.28% (3)
14
TYPE OF REPORTING PERSON
 
PN
 
(1)  Comprised of an aggregate of 3,514,302 shares of common stock, warrants to purchase 324,736 shares of common stock and  5,000,951 shares of common stock issuable as of September 10, 2010 upon the conversion of an aggregate of 36,807 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P.
 
(2)  See footnote 18 in Item 5 below.
 
(3)  Based on 21,234,309 outstanding shares of common stock of the Company as of September 10, 2010, as set forth as the approximate number of shares outstanding in the Company's Current Report on Form 8-K filed on September 14, 2010.
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 3 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Special Situations Fund, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
832,113 Shares (4)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
832,113 Shares (2)(4)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
832,113 Shares (4)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.85% (5)
14
TYPE OF REPORTING PERSON
 
PN
 
(4)    Comprised of  481,079 shares of common stock, warrants to purchase 21,415 shares of common stock and 329,619 shares of common stock issuable as of September 10, 2010 upon the conversion of 2,426 shares of Series A-1 Convertible Preferred Stock.
 
(5)   See footnote 3 above.
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 4 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Private Design Fund, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
3,067,026 Shares (6)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
3,067,026 Shares (2)(6)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,067,026 Shares (6)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.25% (7)
14
TYPE OF REPORTING PERSON
 
PN
 
(6)  Comprised of  1,161,724 shares of common stock, warrants to purchase 116,172 shares of common stock and 1,789,130 shares of common stock issuable as of September 10, 2010 upon the conversion of 13,168 shares of Series A-1 Convertible Preferred Stock.
 
(7)  See footnote 3 above.
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 5 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Private Design International, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
British Virgin Islands

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
4,940,850 Shares (8)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
4,940,850 Shares (2)(8)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
4,940,850 Shares (8)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
20.33% (9)
14
TYPE OF REPORTING PERSON
 
PN
 
(8)  Comprised of  1,871,499 shares of common stock, warrants to purchase 187,150 shares of common stock and 2,882,201 shares of common stock issuable as of September 10, 2010 upon the conversion of 21,213 shares of Series A-1 Convertible Preferred Stock.
 
(9)  See footnote 3 above.
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 6 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Management Company, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
1,506,546 Shares (10)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
1,506,546 Shares (2)(10)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,506,546 Shares (10)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.89% (11)
14
TYPE OF REPORTING PERSON
 
PN
 
(10)  Comprised of 862,949 shares of common stock, warrants to purchase 39,250 shares of common stock and 604,347 shares of common stock issuable as of September 10, 2010 upon the conversion of 4,448 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund International Limited.

(11)  See footnote 3 above.
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 7 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
Deerfield Special Situations Fund International Limited
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
WC
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
British Virgin Islands

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
1,506,546 Shares (12)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
1,506,546 Shares (2)(12)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,506,546 Shares (12)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.89% (13)
14
TYPE OF REPORTING PERSON
 
CO
 
(12)  Comprised of 862,949 shares of common stock, warrants to purchase 39,250 shares of common stock and 604,347 shares of common stock issuable as of September 10, 2010 upon the conversion of 4,448 shares of Series A-1 Convertible Preferred Stock.

(13)  See footnote 3 above.
 
 
 

 
 
SCHEDULE 13D
CUSIP No. 40963P204
 
Page 8 of 13 Pages
 
1
NAME OF REPORTING PERSONS
 
James E. Flynn
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
 
 
  (a) o
  (b) x
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
¨
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States of America

 
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
 
0
8
SHARED VOTING POWER
 
10,346,534 Shares (14)
9
SOLE DISPOSITIVE POWER
 
0
10
SHARED DISPOSITIVE POWER
 
10,346,534 Shares (2)(14)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
10,346,534 Shares (14)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
38.03% (15)
14
TYPE OF REPORTING PERSON
 
IN
 
(14)  Comprised of an aggregate of 4,377,251 shares of common stock, warrants to purchase 363,986 shares of common stock and, 5,605,298 shares of common stock issuable as of September 10, 2010 upon the conversion of an aggregate of 41,255 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P. and Deerfield Special Situations Fund International Limited.

(15)  See footnote 3 above.
 
 
 

 
 
CUSIP No. 40963P204
 
 
 
The Schedule 13D filed on October 19, 2009 by (i) Deerfield Capital, L.P. (“Deerfield Capital”), (ii) Deerfield Special Situations Fund, L.P. (“Deerfield Special Situations Fund”), (iii) Deerfield Private Design Fund, L.P. (“Deerfield Private Design Fund”), (iv) Deerfield Private Design International, L.P. (“Deerfield Private Design International”), (v) Deerfield Management Company, L.P. (“Deerfield Management”), (vi) Deerfield Special Situations Fund Intern ational Limited (“Deerfield Special Situations International”) and (vii) James E. Flynn, a natural person (“Flynn” and collectively with Deerfield Capital, Deerfield Special Situations Fund, Deerfield Private Design Fund, Deerfield Private Design International, Deerfield Management and Deerfield Special Situations International, the “Reporting Persons”), as amended by Amendment No. 1 filed on June 11, 2010 with respect to the securities of Hana Biosciences, Inc. is hereby amended by this Amendment No. 2. Only those items hereby reported in this Amendment No. 2 are amended and all other items remain unchanged.  Terms used herein but not otherwise defined herein shall have the meanings ascribed thereto in Amendment No.1 to the Schedule 13D.

Item 4.
Purpose of Transaction.

Item 4 of the Schedule 13D is amended to include the following:

The Stockholder Approval was obtained on September 2, 2010.  In connection with the Stockholder Approval, among other things, the Company effectuated a one for four reverse stock split of the common stock.  Pursuant to the terms of the Investment Agreement, on September 10, 2010 the Company issued 1,255 shares of Series A-1 Preferred  Stock to the Deerfield Purchasers.

Item 5.
Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is amended and restated to read as follows:
 
(a)
 
 
(1)
Reporting Persons
 
Number of shares: 10,346,534 (16)
Percentage of shares: 38.03% (17)
 
 
(2)
Deerfield Capital
 
Number of shares: 8,839,989 (1)
Percentage of shares: 33.28% (17)
 
 
(3)
Deerfield Special Situations Fund
 
Number of shares: 832,113 (4)
Percentage of shares: 3.85% (17)
 
 
(4)
Deerfield Private Design Fund

Number of shares: 3,067,026 (6)
Percentage of shares: 13.25% (17)
 
 
 

 
 
CUSIP No. 40963P204
 
 
 
 
(5)
Deerfield Private Design International
 
Number of shares: 4,940,850(8)
Percentage of shares: 20.33% (17)
 
 
(6)
Deerfield Management
 
Number of shares: 1,506,546 (10)
Percentage of shares: 6.89% (17)
 
 
(7)
Deerfield Special Situations International

Number of shares: 1,506,546 (12)
Percentage of shares: 6.89% (17)
 
 
(8)
Flynn

Number of shares: 10,346,534 (14)
Percentage of shares: 38.03% (17)
 
(b)

 
(1)
Deerfield Capital
 
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 8,839,989 shares (1)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 8,839,989 shares (1)
 
 
(2)
Deerfield Special Situations Fund

Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 832,113 shares (4)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 832,113 shares (4)
 
 
(3)
Deerfield Private Design Fund

Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 3,067,026 shares (6)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 3,067,026 shares (6)
 
 
(4)
Deerfield Private Design International

Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 4,940,850 shares (8)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 4,940,850 shares (8)
 
 
 

 
 
CUSIP No. 40963P204
 
 
 
 
(5)
Deerfield Management
 
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,506,546 shares (10)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 1,506,546 shares (10)
 
 
(6)
Deerfield Special Situations International

Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,506,546 shares (12)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 1,506,546 shares (12)
 
 
(7)
Flynn

Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 10,346,534 shares (14)
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or direct the disposition: 10,346,534 shares (14)
 
Flynn is the managing member of the general partner of each of Deerfield Capital and Deerfield Management.  Deerfield Capital is the general partner of Deerfield Special Situations Fund, Deerfield Private Design Fund and Deerfield Private Design International.  Deerfield Management is the investment manager of Deerfield Special Situations International.

(16)  Comprised of an aggregate of 4,377,251 shares of common stock, warrants to purchase 363,986 shares of common stock and, as of September 10, 2010,  5,605,298 shares of common stock issuable as of September 10, 2010 upon the conversion of an aggregate of 41,255 shares of Series A-1 Convertible Preferred Stock held by Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P. and Deerfield Special Situations Fund International Limited.

(17)  See footnote 3 above.

(c)  On September 10, 2010, Deerfield Special Situations Fund acquired 73 shares of Series A-1 Preferred Stock, Deerfield Private Design Fund acquired 401 shares of Series A-1 Preferred Stock, Deerfield Private Design International acquired 646 shares of Series A-1 Preferred Stock and Deerfield Special Situations International acquired 135 shares of Series A-1 Preferred Stock as Additional Series A-1 Preferred Shares pursuant to the terms of the Investment Agreement. Shares of Series A-1 Preferred Stock are convertible into Common Stock.
 
Except as described in this Schedule 13D, during the last sixty (60) days there were no transactions in the Common Stock effected by the Reporting Persons, nor, to the best of their knowledge, by any of their directors, executive officers, general partners or members.

(d)  None

(e)  Not applicable
 
 
 

 
 
CUSIP No. 40963P204
 
 
 
SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
 
Dated:  September 16, 2010
 
 
DEERFIELD CAPITAL, L.P.
       
 
By: 
J.E. Flynn Capital LLC, General Partner  
       
 
By: 
/s/ Darren Levine  
 
Name: 
Darren Levine  
 
Title:
Authorized Signatory  

 
DEERFIELD SPECIAL SITUATIONS FUND, L.P.
       
 
By: 
Deerfield Capital, L.P., General Partner  
       
 
By: 
J.E. Flynn Capital LLC, General Partner  
       
 
By: 
/s/ Darren Levine  
 
Name: 
Darren Levine  
 
Title:
Authorized Signatory  
 
 
DEERFIELD PRIVATE DESIGN FUND, L.P.
       
 
By: 
Deerfield Capital, L.P., General Partner  
       
 
By: 
J.E. Flynn Capital LLC, General Partner  
       
 
By: 
/s/ Darren Levine  
 
Name: 
Darren Levine  
 
Title:
Authorized Signatory  
 
 
DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.
       
 
By: 
Deerfield Capital, L.P., General Partner  
       
 
By: 
J.E. Flynn Capital LLC, General Partner  
       
 
By: 
/s/ Darren Levine  
 
Name: 
Darren Levine  
 
Title:
Authorized Signatory  
 
 
DEERFIELD MANAGEMENT COMPANY, L.P.
       
 
By: 
Flynn Management LLC, General Partner  
       
 
By: 
/s/ Darren Levine  
 
Name: 
Darren Levine  
 
Title:
Authorized Signatory  

 
DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED
 
       
 
By: 
/s/ Darren Levine  
 
Name: 
Darren Levine  
 
Title:
Authorized Signatory  
       
 
JAMES E. FLYNN
 
       
 
/s/ Darren Levine
 
 
Darren Levine, Attorney-in-Fact
 

 
-----END PRIVACY-ENHANCED MESSAGE-----